Cargando…
Pancreatic Cancer Gene Therapy: From Molecular Targets to Delivery Systems
The continuous identification of molecular changes deregulating critical pathways in pancreatic tumor cells provides us with a large number of novel candidates to engineer gene-targeted approaches for pancreatic cancer treatment. Targets—both protein coding and non-coding—are being exploited in gene...
Autores principales: | Fillat, Cristina, Jose, Anabel, Ros, Xavier Bofill-De, Mato-Berciano, Ana, Maliandi, Maria Victoria, Sobrevals, Luciano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756366/ https://www.ncbi.nlm.nih.gov/pubmed/24212620 http://dx.doi.org/10.3390/cancers3010368 |
Ejemplares similares
-
AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB mediated uPAR activation
por: Maliandi, Maria Victoria, et al.
Publicado: (2015) -
A NOTCH-sensitive uPAR-regulated oncolytic adenovirus effectively suppresses pancreatic tumor growth and triggers synergistic anticancer effects with gemcitabine and nab-paclitaxel
por: Mato-Berciano, Ana, et al.
Publicado: (2017) -
Intraductal Delivery of Adenoviruses Targets Pancreatic Tumors in Transgenic Ela-myc Mice and Orthotopic Xenografts
por: José, Anabel, et al.
Publicado: (2013) -
Late-phase miRNA-controlled oncolytic adenovirus for selective killing of cancer cells
por: Bofill-De Ros, Xavier, et al.
Publicado: (2015) -
Implications of MicroRNAs in Oncolytic Virotherapy
por: Bofill-De Ros, Xavier, et al.
Publicado: (2017)